HIV+Hep in the News

Wellness Wednesday: RSV cases among children, mental health initiatives, and HIV prevention

As COVID-19 cases continue to rise across the country in children, another virus is making kids sick in unusually large numbers: respiratory syncytial virus, better known as RSV. Today on Wellness Wednesday on All Sides with Ann Fisher, what’s behind the surge of RSV. We’ll also talk about a Columbus City Schools mental health initiative with the Buckeye Ranch and then HIV prevention care.

read more

To stop HIV, researchers are Investigating an mRNA vaccine

An early stage clinical trial of an mRNA-based HIV vaccine could begin this month, according to the U.S. National Library of Medicine clinical trial registry. This vaccine candidate uses technology developed by biotech company Moderna — the same technology used for its highly effective COVID-19 vaccine. The trial, which builds on earlier research by the International AIDS Vaccine Initiative and Scripps Research, would test the first stage of a multistep vaccine regimen. The eventual goal is to stimulate the immune system to produce broadly neutralizing antibodies that target multiple HIV strains.

read more

Pin It on Pinterest

Share This